|Year : 2016 | Volume
| Issue : 4 | Page : 414-419
Role of laparoscopy in hepatobiliary malignancies
Prabhu Arumugam1, Vickna Balarajah2, Jennifer Watt1, Ajit T Abraham2, Satyajit Bhattacharya2, Hemant M Kocher1
1 Centre for Tumour Biology, Barts Cancer Institute – a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square; Barts & the London HPB Centre, The Royal London Hospital, London, UK
2 Barts & the London HPB Centre, The Royal London Hospital, London, UK
|Date of Submission||29-Dec-2015|
|Date of Web Publication||21-Jun-2016|
Hemant M Kocher
Centre for Tumour Biology, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ
Source of Support: None, Conflict of Interest: None
| Abstract|| |
The many benefits of laparoscopy, including smaller incision, reduced length of hospital stay and more rapid return to normal function, have seen its popularity grow in recent years. With concurrent improvements in non-surgical cancer management the importance of accurate staging is becoming increasingly important. There are two main applications of laparoscopic surgery in managing hepato-pancreatico-biliary (HPB) malignancy: accurate staging of disease and resection. We aim to summarize the use of laparoscopy in these contexts. The role of staging laparoscopy has become routine in certain cancers, in particular T staged, locally advanced gastric cancer, hilar cholangiocarcinoma and non-Hodgkin's lymphoma. For other cancers, in particular colorectal, laparoscopy has now become the gold standard management for resection such that there is no role for stand-alone staging laparoscopy. In HPB cancers, although staging laparoscopy may play a role, with ever improving radiology, its role remains controversial.
Keywords: Cholangiocarcinoma - colorectal - gallbladder cancer - hepatobiliary malignancies - laparoscopy - perioperative morbidity - ultrasound
|How to cite this article:|
Arumugam P, Balarajah V, Watt J, Abraham AT, Bhattacharya S, Kocher HM. Role of laparoscopy in hepatobiliary malignancies. Indian J Med Res 2016;143:414-9
|How to cite this URL:|
Arumugam P, Balarajah V, Watt J, Abraham AT, Bhattacharya S, Kocher HM. Role of laparoscopy in hepatobiliary malignancies. Indian J Med Res [serial online] 2016 [cited 2021 Sep 18];143:414-9. Available from: https://www.ijmr.org.in/text.asp?2016/143/4/414/184300
| Introduction|| |
Since Kurt Semm, pioneer in laparoscopic appendectomy performed the first laparoscopic cholecystectomy almost 30 years ago, minimally invasive surgery heralded the promise of less pain, shorter hospital stays, fewer complications and smaller scars as compared to open surgical procedures, most likely due to reduced tissue trauma and inflammatory response. The benefits of laparoscopic approach vary according to the type of procedure, as some procedures show advantages over open surgery, and others only moderate improvements. As techniques and equipment have improved, minimally invasive surgery (MIS) has played an increasing role in the management of some gastrointestinal malignancies. Initial concerns over the use of laparoscopic surgery in gastrointestinal malignancy surrounded the extent of laparoscopic oncological resection, adequate lymph node staging and the possibility of peritoneal tumour seeding.
Each surgical speciality began prospective randomized trials to compare laparoscopic assisted and open surgery for curable cancer. The completion of the Clinical Outcomes of Surgical Therapy (COST) trial that randomized 872 patients with colonic adenocarcinoma to open versus laparoscopically assisted colectomy demonstrated that there was no significant difference in terms of local recurrence and overall survival at three years. This study, along with multiple other landmark studies has led the way for consideration of the utility of MIS surgery for cancer.
Multiple large scale retrospective reviews have confirmed initial promise of laparoscopic surgery, demonstrating reductions in peri-operative morbidity,, length of hospital stay and pain, and improvement in quality of life. Apart from smaller incisions, laparoscopic surgery is also associated with reduced wound infections,, and incidence of incisional hernia. Costs of laparoscopic procedures are higher than those of open procedures, requiring specialist and, often, disposable equipment; however, the reduced length of hospital stay reduces the overall cost of laparoscopic surgery.
Laparoscopy has recently become the gold standard management in certain gastrointestinal conditions.
It enables direct inspection of intra-abdominal organs to facilitate biopsy, cultures and aspirates, and allows the use of intra-operative ultrasound to make therapeutic interventions.
In patients with suspected abdominal malignancy if preoperative oncological assessment is unable to identify metastatic disease, laparoscopy could help to correctly stage the disease and prevent unnecessary laparotomy in these patients. Clements et al identified metastatic disease by laparoscopy which was not seen on preoperative imaging in 37 per cent patients with oesphagogastric carcinoma. Preventing unnecessary laparotomy with laparoscopy was associated with decreased hospital stay and early administration of systemic chemotherapy. The aim of this review is to define the role of laparoscopy in the management of hepato-pancreatico-biliary (HPB) cancers, aiming to distinguish the use as a diagnostic tool and as an approach for curative resection.
Cholagiocarcinoma often presents late with local or metastatic disease meaning that curative surgical resection is not an option. Up to 45 per cent of patients thought to have resectable disease on preoperative radiological imaging are found to have locally advanced or metastatic disease at the time of surgery,,. Patients with locally advanced hilar cholangiocarcinoma are most likely to require open resection. These patients, therefore, may be spared unnecessary laparotomy if staging laparoscopy is carried out to detect those with inoperable disease prior to laparotomy. In addition, an analysis of 175 patients with suspected hilar cholangiocarcinoma diagnoses over ten years found the increasing accuracy and reliability of radiological imaging. this has reduced the requirement of laparoscopy in identifying unresectable disease in recent years,.
Although laparoscopic resection of intrahepatic cholangiocarcinoma has been performed, there are limited case reports,,. These only describe laparoscopic surgery in patients who have solitary intrahepatic lesions. There are no randomized controlled trials or large meta-analyses considering laparoscopic versus open resection for intrahepatic cholagiocarcinoma.
| Hepatocellular carcinoma/colorectal liver metastasis (HCC/ CRLM)|| |
The use of staging laparoscopy has been shown to reduce the number of futile laparotomies carried out for patients with liver metastases, particularly in selected high-risk patients,,. The nature of any previous surgery and related complications must be considered; a colorectal resection complicated with post-operative sepsis may lead to an obliterated abdominal cavity precluding laparoscopy,. These risks, as well as overall patient fitness should be considered when selecting patients for staging laparoscopy. However, with increasing accuracy and availability of positron emission tomography (PET), computed tomography (CT) and magnetic resonance imaging (MRI) the role of staging laparoscopy in hepatic tumours may be diminishing,.
The International Position on Laparoscopic Surgery - The Louisville Statement published in 200828 divided liver resections into three categories; (i) biopsies and small wedge resections, (ii) resection of the left liver, segments IVb, V and VI, and (iii) hemihepatectomies and resections of segments IVa, VII and VIII; type (iv) resections are considered to be major resections. The consensus was that all types of laparoscopic resection are feasible and safe when carried out by experienced surgeons in specialist centres. Moreover, laparoscopic surgery should be considered the preferred treatment for all solitary liver lesions under 5 cm in diameter and situated in the left lateral segments. Furthermore, the long-term outcome of laparoscopic resection is comparable with open resection both in terms of overall survival and disease free survival. Hand assisted laparoscopic liver resection may reduce the need for conversion to full open surgery and help to control haemorrhage,.
| Gallbladder cancer|| |
Patients without evidence of nodal or distant metastases on the basis of preoperative investigations should be considered suitable for surgical resection for gallbladder cancer. The extent of the planned surgery is dependent on this staging process. However, this is an uncommon clinical scenario, usually only applicable to those who have had a diagnosis of gallbladder cancer, as an incidental finding at cholecystectomy.
When considering incidental gallbladder cancer diagnosed at the time of cholecystectomy, patients with T disease can be considered fully treated with simple cholecystectomy alone provided the cystic duct margin is negative. Those found to have a positive cystic duct margin should be re-explored and undergo bile duct excision, lymphadenectomy and biliary enteric anastomosis. T or above primary tumour is most likely to require resection of the gallbladder bed,. Laparoscopic liver resection in those cases that do not also require bile duct excision has been shown to be a feasible and safe procedure with low rates of local recurrence and acceptable R0 resection rates compared with open surgery,. However, there is no randomized controlled trial to date for the use of laparoscopic liver resection for completion surgery for gallbladder cancer compared with open surgery. There had been no large case series using the laparoscopic approach to treat patients requiring common bile duct excision.
Gallbladder cancer is rare and has insidious symptoms. It is, therefore, often diagnosed late and carries poor prognosis. There has been in increase in the diagnosis of incidental gallbladder cancer an recent years as a result of the increasing number of elective cholecystectomies done in the UK,. In patients with high clinical suspicion of gallbladder cancer on the basis of CT and PET imaging, staging laparoscopy has been shown to be of benefit in completing the staging process and as with other cancers preventing unnecessary invasive surgery,.
| Pancreatic cancer|| |
Staging laparoscopy in pancreatic cancer remains under debate. In the age of high resolution CT, Schnelldorfer et al investigated the role of staging laparoscopy at identifying radiographic occult metastases. They noted two per cent of cases where radiographic localized disease had distant metastases. However, comparing these rates with laparotomy, an additional nine per cent of cases were noted to have metastases. Many of these metastases were located to the posterior surface of the liver, paraduodenal areas, proximal jejunal mesentry and lesser sac. Their conclusion was to offer all patients with radiographic localized disease a staging laparoscopy, but to extend it to include assessment and visualization of the lesser sac, proximal jejunal mesentry, mobilisation of duodenum and posterior surface of the liver.
Laparoscopic distal pancreatectomy has been shown in several meta-analyses to be safe and to provide similar oncological outcomes as open surgery,,. All of these studies found reduced length of hospital stay and less blood loss with laparoscopic compared with open surgery. In one meta-analysis of 1,935 patients there was also no difference in resection margins between patients undergoing laparoscopic or open distal pancreatectomy.
The first laparoscopic pancreaticoduodenectomy was reported in 1994 but due to the complexity of the procedure uptake has been much slower than with other laparoscopic procedures. There have been no meta-analyses of laparoscopic pancreaticoduodenectomy but there are several case series. Large case series have shown that completely laparoscopic pancreaticoduodenectomy can be carried out safely and with acceptable morbidity and mortality compared with open surgery,,. Pancreatic fistula rates ranged between 1 and 18 per cent in cases series and overall mortality of 1 to 6 per cent. Negative resection margins were reported in 97-100 per cent of cases,.
| Conclusion|| |
Staging laparoscopy is an invaluablepart of the final assessment ofpatientswith certainHPB malignancies (Table 1) being considered for curative resection, since non-invasive imaging may be unable to detectsmall liver or peritoneal metastasis. Laparoscopic assessment provides a magnified view along with the ability to use laparoscopic ultrasound. Surgeons are, therefore, able to visualizeoccult liver metastases or local tumour invasion into major vessels that would prevent curative resection. By performing the procedure, a surgeon may spare the patient a futile laparotomy that comes with increased surgical risk, pain and longer hospital stay. Undergoing such a laparotomy may also delay any subsequent oncological treatment until the patient is fully recovered. The role of staging laparoscopy has become routine in certain cancers, in particular T staged, locally advanced gastric cancer, hilar cholangiocarcinoma and non-Hodgkin's lymphoma.
In many cancers laparoscopic resection is now the standard management strategy. in these conditions, therefore, a separate staging laparoscopy would be of no value and would only expose the patient to additional risk. Furthermore, there has been great advancement in the accuracy of radiological staging across the board which has reduced the value of staging laparoscopy in the management of colorectal cancer in particular which is staged only using CT, MRI and PET scanning. In assessment of liver tumours its role remains uncertain and for assessment of liver metastases it has been suggested that staging laparoscopy has been superseded by high quality CT, MRI and PET scanning.
| Acknowledgment|| |
The first three authors (PA, VB, JW) acknowledge the Lewin International Surgical Oncology Fellowship.
Conflicts of Interest:
| References|| |
Bhattacharya K. Kurt Semm. A laparoscopic crusader. J Mimim Access Surg
2007; 3 : 35-6.
Ribeiro SC, Ribeiro RM, Santos NC, Pinotti JA. A randomized study of total abdominal, vaginal and laparoscopic hysterectomy. Int J Gynaecol Obstet
2003; 83 : 37-43.
Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg
2006; 93 : 921-8.
Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al
. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res
2004;64 : 2634-8.
Tjandra JJ, Chan MK. Systematic review on the short-term outcome of laparoscopic resection for colon and rectosigmoid cancer. Colorectal Dis
2006; 8 : 375-88.
Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev
2006; 4 : CD
Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies. part 1. Surg Endosc
2010; 24 : 304-34.
Temple LK, Litwin DE, McLeod RS. A meta-analysis of laparoscopic versus open appendectomy in patients suspected of having acute appendicitis. Can J Surg
1999; 42 : 377-83.
Schwenk W, Haase O, Neudecker J, Muller JM. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev
2005; 3 : CD003145.
Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, et al
. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg
2001; 234 : 279-89.
Duepree HJ, Senagore AJ, Delaney CP, Fazio VW. Does means of access affect the incidence of small bowel obstruction and ventral hernia after bowel resection? Laparoscopy versus laparotomy. J Am Coll Surg
2003; 197 : 177-81.
Noblett SE, Horgan AF. A prospective case-matched comparison of clinical and financial outcomes of open versus laparoscopic colorectal resection. Surg Endosc
2007; 21 :404-8.
Clements DM, Bowrey DJ, Havard TJ. The role of staging investigations for oesophago-gastric carcinoma. Eur J Surg Oncol
2004; 30 : 309-12.
Grobmyer SR, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH, Jarnagin WR. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg
2004; 139 : 1326-30.
Barlow AD, Garcea G, Berry DP, Rajesh A, Patel R, Metcalfe MS, et al
. Staging laparoscopy for hilar cholangiocarcinoma in 100 patients. Langenbecks Arch Surg
2013; 398 : 983-8.
Ruys AT, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma. HPB Surg
2013; 2013 : 657309.
Rotellar F, Pardo F. Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified? World j gastrointest oncolo 2013; 5 : 127-31.
Ruys AT, Busch OR, Gouma DJ, van Gulik TM. Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile? Ann Surg Oncol 2011; 18 : 2647-53.
Hariharan D, Constantinides VA, Froeling FE, Tekkis PP, Kocher HM. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers--A meta-analysis. Eur J Surg Oncol
2010; 36 : 941-8.
Abu Hilal M, Badran A, Di Fabio F, Pearce NW. Pure laparoscopic en bloc left hemihepatectomy and caudate lobe resection in patients with intrahepatic cholangiocarcinoma. J laparoendosc adv surg tech A
2011; 21 : 845-9.
Machado MA, Makdissi FF, Surjan RC, Mochizuki M. Laparoscopic resection of hilar cholangiocarcinoma. J laparoendosc adv surg tech A
2012; 22 : 954-6.
Giulianotti PC, Sbrana F, Bianco FM, Addeo P. Robot-assisted laparoscopic extended right hepatectomy with biliary reconstruction. J laparoendosc adv surg tech A
2010; 20 : 159-63.
Pilkington SA, Rees M, Peppercorn D, John TG. Laparoscopic staging in selected patients with colorectal liver metastases as a prelude to liver resection. HPB (Oxford) 2007; 9 : 58-63.
Shah AJ, Phull J, Finch-Jones MD. Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases. World J Surg
2010; 34 : 2141-5.
Khan AZ, Karanjia ND. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases. Eur J Surg Oncol
2007; 33 : 1010-3.
Dunne DF, Gaughran J, Jones RP, McWhirter D, Sutton PA, Malik HZ, et al
. Routine staging laparoscopy has no place in the management of colorectal liver metastases. Eur J Surg Oncol
2013; 39 : 721-5.
Hariharan D, Constantinides V, Kocher HM, Tekkis PP. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of patients with resectable colorectal liver metastases: a meta-analysis. Am J Surg
Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, et al
. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg
2009; 250 : 825-30.
Iwahashi S, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, et al
. Laparoscopic hepatic resection for metastatic liver tumor of colorectal cancer: comparative analysis of short- and long-term results. Surg Endosc
2014; 28 : 80-4.
Afaneh C, Kluger MD. Laparoscopic liver resection: lessons at the end of the second decade. Semin Liver Dis
2013; 33 : 226-35.
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver
2012; 6 : 172-87.
Isambert M, Leux C, Metairie S, Paineau J. Incidentally-discovered gallbladder cancer: When, why and which reoperation? J visc surg 2011; 148 : e77-84.
Kwon AH, Imamura A, Kitade H, Kamiyama Y. Unsuspected gallbladder cancer diagnosed during or after laparoscopic cholecystectomy. J Surg Oncol
2008; 97 : 241-5.
Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol 2012; 27 : 642-53.
Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. Gallbladder cancer. Am J Surg
2008; 196 : 252-64.
Schnelldorfer T, Gagnon AI, Birkett RT, Reynolds G, Murphy KM, Jenkins RL. Staging laparoscopy in pancreatic cancer: a potential role for advanced laparoscopic techniques. J Am Coll Surg
2014; 218 : 1201-6.
Nakamura M, Nakashima H. Laparoscopic distal pancreatectomy and pancreatoduodenectomy: is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J hepatobiliary pancreat sci
2013; 20 : 421-8.
Sui CJ, Li B, Yang JM, Wang SJ, Zhou YM. Laparoscopic versus open distal pancreatectomy: a meta-analysis. Asian j surg
2012; 35 : 1-8.
Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg
2012; 255 : 1048-59.
Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc
1994; 8 : 408-10.
Kendrick ML, Cusati D. Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg
2010; 145 : 19-23.
Kim SC, Song KB, Jung YS, Kim YH, Park do H, Lee SS, et al
. Short-term clinical outcomes for 100 consecutive cases of laparoscopic pylorus-preserving pancreatoduodenectomy: improvement with surgical experience. Surg Endosc
2013;27 : 95-103.
Palanivelu C, Rajan PS, Rangarajan M, Vaithiswaran V, Senthilnathan P, Parthasarathi R, et al
. Evolution in techniques of laparoscopic pancreaticoduodenectomy: a decade long experience from a tertiary center. J Hepatobiliary Pancreat Surg
2009; 16 : 731-40.
Kim YW, Yoon HM, Yun YH, Nam BH, Eom BW, Baik YH, et al
. Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc
2013; 27 :4267-76.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al
. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet
2005; 365 : 1718-26.
Chiu CC, Wei PL, Huang MT, Wang W, Chen TC, Lee WJ. Laparoscopic treatment of ileocecal intussusception caused by primary ileal lymphoma. Surg Laparosc Endosc Percutan Tech
2004; 14 : 93-5.
|This article has been cited by|
||Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
| ||Michelle R. Goulart,Jennifer Watt,Imran Siddiqui,Rita T. Lawlor,Ahmet Imrali,Christine Hughes,Amina Saad,Joanne ChinAleong,Chris Hurt,Catrin Cox,Roberto Salvia,Alberto Mantovani,Tatjana Crnogorac-Jurcevic,Somnath Mukherjee,Aldo Scarpa,Paola Allavena,Hemant M. Kocher |
| ||npj Precision Oncology. 2021; 5(1) |
|[Pubmed] | [DOI]|
||Surgical Technique and Clinical Analysis of Twelve Cases of Isolated Laparoscopic Resection of the Hepatic Caudate Lobe
| ||Bin Jin,Zhengchen Jiang,Sanyuan Hu,Gang Du,Binyao Shi,Du Kong,Jinhuan Yang |
| ||BioMed Research International. 2018; 2018: 1 |
|[Pubmed] | [DOI]|
||Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives
| ||Hai-Jie Hu,Zhen-Ru Wu,Yan-Wen Jin,Wen-Jie Ma,Qin Yang,Jun-Ke Wang,Fei Liu,Fu-Yu Li |
| ||ANZ Journal of Surgery. 2018; |
|[Pubmed] | [DOI]|